{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:30:02Z","timestamp":1786631402443,"version":"build-2736575974"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neuroscience.2024.12.009","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T16:16:46Z","timestamp":1733588206000},"page":"292-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Molecular basis of the development of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"565","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1326-7383","authenticated-orcid":false,"given":"Margarita","family":"Absalyamova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0424-6545","authenticated-orcid":false,"given":"Dmitrii","family":"Traktirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Burdinskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Artemova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2789-8431","authenticated-orcid":false,"given":"Zamira","family":"Muruzheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Karpenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.12.009_b0005","first-page":"1","article-title":"Parkinson\u2019s disease motor symptoms in machine learning: a review","volume":"2","author":"Ahlrichs","year":"2013","journal-title":"Heal. Informatics - Int. J."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.parkreldis.2007.09.005","article-title":"Activation of the calpain\/cdk5\/p25 pathway in the girus cinguli in Parkinson\u2019s disease","volume":"14","author":"Alvira","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094676","article-title":"The Contribution of microglia to neuroinflammation in Parkinson\u2019s disease","volume":"22","author":"Badanjak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbi.2009.09.001","article-title":"Minimal penetration of lipopolysaccharide across the murine blood-brain barrier","volume":"24","author":"Banks","year":"2010","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0025","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4103\/1673-5374.270297","article-title":"Locus coeruleus-norepinephrine: basic functions and insights into Parkinson\u2019s disease","volume":"15","author":"Bari","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092293","article-title":"Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration","volume":"20","author":"Batista","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tins.2016.01.007","article-title":"Calpain-1 and Calpain-2: the Yin and Yang of synaptic plasticity and neurodegeneration","volume":"39","author":"Baudry","year":"2016","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/14728222.2013.766169","article-title":"Targeting calpain in synaptic plasticity","volume":"17","author":"Baudry","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0753-3322(99)80079-1","article-title":"IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson\u2019s disease","volume":"53","author":"Bessler","year":"1999","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0050","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1042\/BST0351127","article-title":"Chronic microglial activation and progressive dopaminergic neurotoxicity","volume":"35","author":"Block","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115450","article-title":"Proteolytic \u03b1-synuclein cleavage in health and disease","volume":"22","author":"Bluhm","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jnc.13029","article-title":"Valproic acid induces neuronal cell death through a novel calpain-dependent necroptosis pathway","volume":"133","author":"Bollino","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0065","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.20937","article-title":"Proteasome inhibition and Parkinson\u2019s disease modeling","volume":"60","author":"Bov\u00e9","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12974-019-1564-7","article-title":"The endotoxin hypothesis of neurodegeneration","volume":"16","author":"Brown","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbi.2009.12.008","article-title":"Methamphetamine sensitization attenuates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus","volume":"24","author":"Buchanan","year":"2010","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0080","first-page":"1","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"9","author":"Chang","year":"2020","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ceca.2017.07.001","article-title":"SERCA control of cell death and survival","volume":"69","author":"Chemaly","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104700","article-title":"Autonomic dysfunction in Parkinson\u2019s disease: Implications for pathophysiology, diagnosis, and treatment","volume":"134","author":"Chen","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/neup.12812","article-title":"Neuropathology of \u03b1-synuclein in Parkinson\u2019s disease","volume":"42","author":"Choong","year":"2022","journal-title":"Neuropathology"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","article-title":"Alterations in lysosomal and proteasomal markers in Parkinson\u2019s disease: relationship to alpha-synuclein inclusions","volume":"35","author":"Chu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/SQB.1995.060.01.053","article-title":"The ubiquitin-mediated proteolytic system: involvement of molecular chaperones, degradation of oncoproteins, and activation of transcriptional regulators","volume":"60","author":"Ciechanover","year":"1995","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0110","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2353\/ajpath.2007.061232","article-title":"Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation","volume":"170","author":"Dufty","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.expneurol.2018.04.012","article-title":"New HSF1 inducer as a therapeutic agent in a rodent model of Parkinson\u2019s disease","volume":"306","author":"Ekimova","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0120","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.7732382","article-title":"Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin","volume":"268","author":"Fenteany","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/bs.pbr.2022.01.013","article-title":"Cognition and serotonin in Parkinson\u2019s disease","volume":"269","author":"Frouni","year":"2022","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0130","article-title":"Calpain activation and progression of inflammatory cycles in Parkinson\u2019s disease","volume":"27","author":"Gao","year":"2022","journal-title":"Front. Biosci. (landmark Ed."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.299","article-title":"Autophagy fails to prevent glucose deprivation\/glucose reintroduction-induced neuronal death due to calpain-mediated lysosomal dysfunction in cortical neurons","volume":"8","author":"Ger\u00f3nimo-Olvera","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pneurobio.2013.10.004","article-title":"Autophagy and apoptosis dysfunction in neurodegenerative disorders","volume":"112","author":"Ghavami","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22042038","article-title":"Copper dependent modulation of \u03b1-synuclein phosphorylation in differentiated SHSY5Y neuroblastoma cells","volume":"22","author":"Greco","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00045","article-title":"Proteostasis of \u03b1-synuclein and its role in the pathogenesis of Parkinson\u2019s disease","volume":"14","author":"Han","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134316","article-title":"\u03b1-Synuclein pathology in Parkinson\u2019s disease and related \u03b1-synucleinopathies","volume":"709","author":"Henderson","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0160","doi-asserted-by":"crossref","unstructured":"H. Hindeya Gebreyesus, T. Gebrehiwot Gebremichael, The Potential Role of Astrocytes in Parkinson\u2019s Disease (PD), Med. Sci. (Basel, Switzerland) 8 (2020) 7. DOI: 10.3390\/MEDSCI8010007.","DOI":"10.3390\/medsci8010007"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0165","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","article-title":"Autophagy in Parkinson\u2019s Disease","volume":"432","author":"Hou","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neures.2017.11.011","article-title":"A low blood copper concentration is a co-morbidity burden factor in Parkinson\u2019s disease development","volume":"135","author":"Ilyechova","year":"2018","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/jpm9030041","article-title":"Case of Early-Onset Parkinson\u2019s Disease in a Heterozygous Mutation Carrier of the ATP7B Gene","volume":"9","author":"Ilyechova","year":"2019","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00726-013-1628-4","article-title":"Protective effect of S-allyl-L-cysteine against endoplasmic reticulum stress-induced neuronal death is mediated by inhibition of calpain","volume":"46","author":"Imai","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0185","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s11011-022-00916-7","article-title":"Protective effect of calpain inhibitors against manganese-induced toxicity in rats","volume":"37","author":"Ivleva","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135344","article-title":"Intranasal exposure of manganese induces neuroinflammation and disrupts dopamine metabolism in the striatum and hippocampus","volume":"738","author":"Ivleva","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0195","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.it.2017.05.001","article-title":"Lipopolysaccharide detection across the kingdoms of life","volume":"38","author":"Kagan","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-4522(00)00077-4","article-title":"Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation","volume":"97","author":"Kanda","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0210","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10517-018-4039-4","article-title":"Role of Copper Dyshomeostasis in the Pathogenesis of Parkinson\u2019s Disease","volume":"164","author":"Karpenko","year":"2018","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","article-title":"Interleukin-1\u03b2, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease","volume":"327","author":"Karpenko","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0220","unstructured":"Z. Khan, S.A. Ali, Oxidative stress-related biomarkers in Parkinson\u2019s disease: A systematic review and meta-analysis, Iran. J. Neurol. 17 (2018) 137. \/pmc\/articles\/PMC6420691\/ (accessed March 13, 2023)."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0225","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0022-510X(95)00180-A","article-title":"Defective production of interleukin-2 in patients with idiopathic Parkinson\u2019s disease","volume":"133","author":"Kl\u00fcter","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.32607\/actanaturae.10934","article-title":"Spinal Cord Microglia in Health and Disease","volume":"12","author":"Kolos","year":"2020","journal-title":"Acta Naturae"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0235","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/(SICI)1096-9861(19990906)411:4<666::AID-CNE10>3.0.CO;2-S","article-title":"Olfactory receptor neurons express D2 dopamine receptors","volume":"411","author":"Koster","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2023.130345","article-title":"Functions and distribution of calpain-calpastatin system components in brain during mammal ontogeny","volume":"1867","author":"Kotova","year":"2023","journal-title":"Biochim. Biophys. Acta. Gen. Subj."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0245","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.intimp.2004.05.006","article-title":"Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson\u2019s disease","volume":"4","author":"Kurkowska-Jastrz\u0229bska","year":"2004","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0250","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awp333","article-title":"Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity","volume":"133","author":"Levesque","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0255","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuint.2017.05.016","article-title":"Nexus between mitochondrial function, iron, copper and glutathione in Parkinson\u2019s disease","volume":"117","author":"Liddell","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0260","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133274","article-title":"Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism","volume":"20","author":"Limanaqi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047387","article-title":"Non-motor symptoms in patients with Parkinson\u2019s disease - correlations with inflammatory cytokines in serum","volume":"7","author":"Lindqvist","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0275","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/mds.22828","article-title":"A comparison of treatment thresholds in two large Parkinson\u2019s disease clinical trial cohorts","volume":"24","author":"Marras","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0280","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.jcbfm.9600080","article-title":"Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic\/ischemic brain injury","volume":"25","author":"Matsumori","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0285","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s11011-021-00755-y","article-title":"Changes in activity of \u00b5- and m-calpains and signs of neuroinflammation in the hippocampus and striatum of rats after single intraperitoneal injection of subseptic dose of endotoxin","volume":"36","author":"Maystrenko","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0290","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042318","article-title":"Involvement of calpain\/p35-p25\/Cdk5\/NMDAR signaling pathway in glutamate-induced neurotoxicity in cultured rat retinal neurons","volume":"7","author":"Miao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/bs.pbr.2022.01.007","article-title":"Functional neuroanatomy of cognition in Parkinson\u2019s disease","volume":"269","author":"Mirpour","year":"2022","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0305","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1471-4159.2003.01878.x","article-title":"Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro","volume":"86","author":"Mishizen-Eberz","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0310","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","article-title":"Interleukin (IL)-1\u03b2, IL-2, IL-4, IL-6 and transforming growth factor-\u03b1 levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson\u2019s disease","volume":"211","author":"Mogi","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0320","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","article-title":"p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain","volume":"414","author":"Mogi","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0325","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12192-017-0792-y","article-title":"Interplay between recombinant Hsp70 and proteasomes: proteasome activity modulation and ubiquitin-independent cleavage of Hsp70","volume":"22","author":"Morozov","year":"2017","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0330","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/01616412.2020.1854004","article-title":"Calpain activity in plasma of patients with essential tremor and Parkinson\u2019s disease: a pilot study","volume":"43","author":"Muruzheva","year":"2021","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0335","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.conb.2021.09.001","article-title":"Synaptic proteostasis in Parkinson\u2019s disease","volume":"72","author":"Nachman","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0340","first-page":"277","article-title":"Changes in cytokines and neurotrophins in Parkinson\u2019s disease","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0345","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1570159X14666151204122017","article-title":"LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals","volume":"14","author":"Nava Catorce","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0350","article-title":"Di Iorio, Incidence of RBD and hallucination in patients affected by Parkinson\u2019s disease: 8-year follow-up","volume":"23 Suppl 2","author":"Onofrj","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0355","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198706043162308","article-title":"Do vasodilators prolong life in heart failure?","volume":"316","author":"Packer","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0360","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease: New Mechanistic Insights and Therapeutic Perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0365","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbi.2004.01.004","article-title":"The influence of systemic inflammation on inflammation in the brain: Implications for chronic neurodegenerative disease","volume":"18","author":"Perry","year":"2004","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0370","doi-asserted-by":"crossref","DOI":"10.1080\/00207454.2021.1901697","article-title":"m-Calpain is released from striatal synaptosomes","volume":"133","author":"Pestereva","year":"2023","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0375","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","article-title":"Autonomic Dysfunction in Parkinson\u2019s Disease","volume":"17","author":"Pfeiffer","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0380","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00161","article-title":"Can Interactions Between \u03b1-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson\u2019s Disease?","volume":"12","author":"Post","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0385","volume":"11","author":"Pyatha","year":"2022","journal-title":"Association between Heavy Metal Exposure and Parkinson\u2019s Disease: A Review of the Mechanisms Related to Oxidative Stress"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0390","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0395","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0400","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/ncb1629","article-title":"Toll-like receptors modulate adult hippocampal neurogenesis","volume":"9","author":"Rolls","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0410","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","article-title":"Glutathione metabolism and Parkinson\u2019s disease","volume":"62","author":"Smeyne","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0415","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0420","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0425","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000097237","article-title":"Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with parkinson\u2019s disease","volume":"3","author":"Stypu\u0142a","year":"1996","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0430","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11011-012-9328-4","article-title":"Region-specific changes in activities of cell death-related proteases and nitric oxide metabolism in rat brain in a chronic unpredictable stress model","volume":"27","author":"Tishkina","year":"2012","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0435","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","article-title":"Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders","volume":"26","author":"Tofaris","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0440","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1073\/pnas.1109356108","article-title":"Ubiquitin ligase Nedd4 promotes \u03b1-synuclein degradation by the endosomal-lysosomal pathway","volume":"108","author":"Tofaris","year":"2011","journal-title":"Proc. Natl. Acad. Sci. u. s. a."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0445","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-11-85","article-title":"Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment","volume":"11","author":"Vasconcelos","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0450","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10534-019-00189-1","article-title":"Looking for a partner: ceruloplasmin in protein-protein interactions","volume":"32","author":"Vasilyev","year":"2019","journal-title":"Biometals"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0455","first-page":"3853","article-title":"Relationship between levels of inflammatory cytokines in the peripheral blood and the severity of depression and anxiety in patients with Parkinson\u2019s disease","volume":"20","author":"Wang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0460","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/WNR.0b013e32835ad25d","article-title":"Differential roles for caspase-mediated and calpain-mediated cell death in 1- and 3-week-old rat cortical cultures","volume":"23","author":"Wang","year":"2012","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0465","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/brain\/awx039","article-title":"A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3","volume":"140","author":"Weber","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0470","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0042-6989(00)00036-5","article-title":"A model of the Parkinsonian visual system: support for the dark adaptation hypothesis","volume":"40","author":"Wink","year":"2000","journal-title":"Vision Res."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0475","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0480","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0304-4165(03)00099-0","article-title":"Natural N-terminal fragments of brain abundant myristoylated protein BASP1","volume":"1622","author":"Zakharov","year":"2003","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0485","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10541-005-0200-6","article-title":"Specific proteolysis of neuronal protein GAP-43 by calpain: characterization, regulation, and physiological role","volume":"70","author":"Zakharov","year":"2005","journal-title":"Biochemistry. (mosc)"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0490","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s13311-020-00963-x","article-title":"Approach to Cognitive Impairment in Parkinson\u2019s Disease","volume":"17","author":"Zhang","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2024.12.009_b0495","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.toxlet.2016.11.002","article-title":"Pathological \u03b1-synuclein exacerbates the progression of Parkinson\u2019s disease through microglial activation","volume":"265","author":"Zhang","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2016.08.023","article-title":"Cdk5\/p25 specific inhibitory peptide TFP5 rescues the loss of dopaminergic neurons in a sub-acute MPTP induced PD mouse model","volume":"632","author":"Zhang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0505","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1007\/s12035-018-1015-y","article-title":"Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration","volume":"55","author":"Zhao","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2024.12.009_b0510","doi-asserted-by":"crossref","unstructured":"S.G. Zubova, I.I. Suvorova, M.N. Karpenko, Macrophage and microglia polarization: focus on autophagy-dependent reprogramming, Front. Biosci. (Schol. Ed). 14 (2022). DOI: 10.31083\/J.FBS1401003.","DOI":"10.31083\/j.fbs1401003"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224007103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224007103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T01:44:24Z","timestamp":1736214264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224007103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":102,"alternative-id":["S0306452224007103"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.009","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular basis of the development of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}